Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 8, Pages -Publisher
MDPI
DOI: 10.3390/ijms23084230
Keywords
SORL1; Alzheimer; homozygous case; cerebral amyloid angiopathy; SorLA immunohistochemistry
Funding
- Instituto de Salud Carlos III [PI17/01067]
- AGAUR from the Autonomous Catalan Government [2017SGR1134]
- Instituto de Salud Carlos III (ISCIII, Spanish Biomedical Research Institute) through a Rio Hortega contract [CM18/0095]
- Instituto de Salud Carlos III (ISCIII
- Spanish Biomedical Research Institute) through a Juan Rodes contract [JR 18/00046]
Ask authors/readers for more resources
The SORL1 gene has been strongly implicated in the development of Alzheimer's disease, with a high proportion of patients with candidate variants having SORL1 variants. This study expands the understanding of the clinical manifestations associated with SORL1 gene by reporting detailed clinical and neuroimaging findings of patients with AD and SORL1 mutations. Furthermore, this study presents new insights into the association of SORL1 variants with severe cerebral amyloid angiopathy and provides evidence that SORL1 might contribute to AD development as a risk factor gene rather than a major autosomal dominant gene.
In the last few years, the SORL1 gene has been strongly implicated in the development of Alzheimer's disease (AD). We performed whole-exome sequencing on 37 patients with early-onset dementia or family history suggestive of autosomal dominant dementia. Data analysis was based on a custom panel that included 46 genes related to AD and dementia. SORL1 variants were present in a high proportion of patients with candidate variants (15%, 3/20). We expand the clinical manifestations associated with the SORL1 gene by reporting detailed clinical and neuroimaging findings of six unrelated patients with AD and SORL1 mutations. We also present for the first time a patient with the homozygous truncating variant c.364C>T (p.R122*) in SORL1, who also had severe cerebral amyloid angiopathy. Furthermore, we report neuropathological findings and immunochemistry assays from one patient with the splicing variant c.4519+5G>A in the SORL1 gene, in which AD was confirmed by neuropathological examination. Our results highlight the heterogeneity of clinical presentation and familial dementia background of SORL1-associated AD and suggest that SORL1 might be contributing to AD development as a risk factor gene rather than as a major autosomal dominant gene.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available